A new federal study is calling for a major change in how the government classifies marijuana. The U.S. Department of Health and Human Services is now asking the Drug Enforcement Agency to "reschedule" cannabis, citing its widely-accepted medicinal use. James Whitcomb, CEO of Frontier Risk explain what "rescheduling" means and its potential impact here and across the nation in a recent interview on FOX5 Washington DC.

‍